When PAX3:FKHR expression was targeted by the Myf6 promoter in terminally differentiating skeletal muscle, mice developed alveaolar rhabdomyosarcoma with a very low penetrance (< 1%). The gene discussed is FOXO1; the disease is rhabdomyosarcoma.